Latest news with #dialysis
Yahoo
16-07-2025
- Business
- Yahoo
Constellation Kidney Group Marks 50 Years of Dialysis Innovation, Introducing KidneyOne to Power the Next Generation of Kidney Care
RICHMOND, Va., July 16, 2025--(BUSINESS WIRE)--Constellation Kidney Group (CKG), a global portfolio of businesses under Miram Solutions within the Perseus Operating Group (Perseus) of Constellation Software Inc. (TSX: CSU), proudly commemorates 50 years of dialysis technology innovation, honoring the legacy of Quantitative Medical Systems Inc. (QMS), founded in Oakland, California in 1976. Acquired by Perseus in 2013, QMS laid the foundation for what is now a global leader in integrated clinical, operational, and analytics solutions for kidney care providers. To mark this milestone, CKG is unveiling a refreshed brand identity and introducing its next-generation product ecosystem: KidneyOne, a fully integrated dialysis management platform; CKG Intelligence, a powerful analytics suite, including the Renal AI predictive care solution; and CKG Exchange, a robust interoperability hub for the future, connecting data across the kidney care continuum. "Celebrating 50 years is a testament to the incredible legacy of QMS and the ongoing commitment of Constellation Kidney Group to empower dialysis providers with technology that makes a meaningful difference," said David Abbott, General Manager of CKG. "As part of the Constellation Software family, our ethos has always been to acquire and nurture vertical market software businesses for the long term, ensuring continuous innovation and lasting value for our customers." CKG's KidneyOne platform brings together its market-leading solutions into a single, unified ecosystem — enhancing workflows, delivering actionable insights, and helping dialysis providers optimize care, operations, and compliance across global markets. "KidneyOne gives providers a smarter, more connected way to run their dialysis operations while supporting better outcomes and reducing costs," said Chris Lutz, General Manager, CKG US. "By uniting best-in-class solutions with AI-driven analytics and integrated workflows in a single platform, we're defining the next generation of dialysis software built to scale for long-term growth." The 50th anniversary milestone reflects CKG's enduring mission to advance kidney care through purpose-built technology, reliability, and long-term partnership. Visit the company's updated website to learn more: About Constellation Kidney Group Constellation Kidney Group (CKG) is a global leader in dialysis technology, delivering purpose-built clinical, financial, and operational solutions that empower kidney care providers worldwide. Formed through the acquisition of leading software innovators beginning in 2013, CKG brings together decades of expertise in KidneyOne — an integrated platform offering modern EHR applications, data-driven intelligence, and seamless interoperability through CKG Exchange. CKG is a global portfolio of businesses under Miram Solutions within the Perseus Operating Group of Constellation Software Inc. (TSX: CSU), and is committed to advancing kidney care through innovation, reliability, and long-term partnership. Learn more at View source version on Contacts Chris Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
National Post
16-07-2025
- Business
- National Post
Constellation Kidney Group Marks 50 Years of Dialysis Innovation, Introducing KidneyOne to Power the Next Generation of Kidney Care
Article content RICHMOND, Va. — Constellation Kidney Group (CKG), a global portfolio of businesses under Miram Solutions within the Perseus Operating Group (Perseus) of Constellation Software Inc. (TSX: CSU), proudly commemorates 50 years of dialysis technology innovation, honoring the legacy of Quantitative Medical Systems Inc. (QMS), founded in Oakland, California in 1976. Acquired by Perseus in 2013, QMS laid the foundation for what is now a global leader in integrated clinical, operational, and analytics solutions for kidney care providers. Article content To mark this milestone, CKG is unveiling a refreshed brand identity and introducing its next-generation product ecosystem: Article content Article content KidneyOne, a fully integrated dialysis management platform; CKG Intelligence, a powerful analytics suite, including the Renal AI predictive care solution; and CKG Exchange, a robust interoperability hub for the future, connecting data across the kidney care continuum. Article content 'Celebrating 50 years is a testament to the incredible legacy of QMS and the ongoing commitment of Constellation Kidney Group to empower dialysis providers with technology that makes a meaningful difference,' said David Abbott, General Manager of CKG. 'As part of the Constellation Software family, our ethos has always been to acquire and nurture vertical market software businesses for the long term, ensuring continuous innovation and lasting value for our customers.' Article content CKG's KidneyOne platform brings together its market-leading solutions into a single, unified ecosystem — enhancing workflows, delivering actionable insights, and helping dialysis providers optimize care, operations, and compliance across global markets. Article content 'KidneyOne gives providers a smarter, more connected way to run their dialysis operations while supporting better outcomes and reducing costs,' said Chris Lutz, General Manager, CKG US. 'By uniting best-in-class solutions with AI-driven analytics and integrated workflows in a single platform, we're defining the next generation of dialysis software built to scale for long-term growth.' Article content The 50th anniversary milestone reflects CKG's enduring mission to advance kidney care through purpose-built technology, reliability, and long-term partnership. Visit the company's updated website to learn more: About Constellation Kidney Group Constellation Kidney Group (CKG) is a global leader in dialysis technology, delivering purpose-built clinical, financial, and operational solutions that empower kidney care providers worldwide. Formed through the acquisition of leading software innovators beginning in 2013, CKG brings together decades of expertise in KidneyOne — an integrated platform offering modern EHR applications, data-driven intelligence, and seamless interoperability through CKG Exchange. CKG is a global portfolio of businesses under Miram Solutions within the Perseus Operating Group of Constellation Software Inc. (TSX: CSU), and is committed to advancing kidney care through innovation, reliability, and long-term partnership. Learn more at Article content Article content
Free Malaysia Today
15-07-2025
- Health
- Free Malaysia Today
Why CKD continues to fly under the radar
CKD is a progressive condition in which the kidneys gradually lose their ability to filter waste and excess fluids from the blood. (Envato Elements pic) PETALING JAYA : The prevalence of chronic kidney disease (CKD) in Malaysia surged from 9.07% in 2011 to 15.48% in 2018, signalling a worrying trend. Today, more than 50,000 Malaysians receive dialysis, according to the health ministry, which projects this number could exceed 100,000 by 2040 if early intervention continues to be elusive. Yet, many remain unaware they might be at risk: the slow, symptomless nature of CKD and lack of public awareness often lead to late diagnosis, after significant and irreversible kidney damage has set in. CKD is a progressive condition in which the kidneys gradually lose their ability to filter waste and excess fluids from the blood. By the time patients experience symptoms like fatigue, bodily swelling, or changes in urination, significant and often irreversible damage has already occurred. 'CKD is a dangerous disease precisely because it hides in plain sight,' explained consultant nephrologist and physician Dr Chong Yip Boon. 'Left undetected, it can result in life-threatening complications such as cardiovascular disease, symptomatic anaemia, metabolic bone diseases, fluid overload and ultimately, irreversible renal failure and death. 'Its insidious onset and silent progressive nature make early detection both challenging and critical. Lack of public awareness and regular health screenings further increase the difficulty in its early diagnosis.' Dr Chong Yip Boon. One of the key reasons CKD is frequently diagnosed at advanced stages is the widespread lack of public awareness and regular checkups. Most individuals do not experience any discomfort or clear symptoms in the early stages of the disease. Even when signs appear, they are often misattributed to other, less serious conditions. The common mindset that 'feeling fine means being healthy' leads to delayed action, especially among high-risk individuals. 'The issue isn't that kidney tests aren't available. In fact, they are included in most health screening packages,' Chong noted. 'The problem is that people simply don't come in for checkups until it's too late.' Screening is especially important for high-risk groups: those with diabetes, hypertension, heart disease, morbid obesity, kidney stones, gout, or a family history of kidney disease. Others include the elderly, frequent users of painkillers or over-the-counter medications, and those who self-medicate regularly. The health ministry projects that, without early intervention, the number of Malaysians who require dialysis could hit 100,000 by 2040. (Bernama pic) In some cases, early signs may be more visible than people realise. For example, abnormal bubbly or foamy urine can be an early indicator of protein loss – a possible sign of kidney damage. A simple urine test with a GP or specialist can determine whether symptoms are benign or related to CKD. Chong places emphasis on practical lifestyle steps to reduce the risk of kidney disease: drink at least 2 litres of water per day (if there are no underlying heart conditions); maintain a healthy and balanced diet; avoid overuse of painkillers, unprescribed supplements, and self-medication; exercise regularly and aim for sustainable weight reduction; avoid or limit smoking and alcohol consumption; schedule routine full-body screenings and checkups to have a more well-informed overview of one's health; manage existing underlying medical conditions such as diabetes, hypertension, high cholesterol, and heart disease. 'Malaysians must begin to see kidney health as an essential part of general wellbeing, not something to think about only when symptoms appear,' Chong stressed. 'Routine screening, especially among at-risk individuals, can lead to early detection, delay disease progression, improve quality of life, and significantly reduce long-term healthcare costs.'
Health Line
12-07-2025
- Health
- Health Line
What Happens If Your Kidneys Fail? Signs and Complications
Key takeaways Kidney failure occurs when the kidneys can no longer filter waste and excess fluid from the blood, leading to a buildup of toxins in the body. Symptoms of kidney failure can include swelling, fatigue, changes in urination, and confusion. Without medical treatment, life expectancy after kidney failure is typically a few weeks, but dialysis or a kidney transplant can significantly extend a person's life. If you have chronic kidney disease (CKD), your kidneys cannot filter waste and excess fluid from your blood as well as they should. But kidney disease is not the same as kidney failure. End-stage kidney failure means important body functions are compromised. You'll feel sick. Your life will even be at risk without medical treatment. CKD is a progressive disease that develops in five stages, meaning that your kidney function gets worse over time. Kidney failure is the fifth and final stage of CKD. Some healthcare professionals call it end-stage renal disease (ESRD). It is possible to stop the progression of CKD before it reaches the fifth stage for some people. Others may not be aware they have CKD until their kidneys fail. Although there's currently no cure for CKD, you can take some steps to slow disease progression and prevent kidney failure. If your kidneys fail, they're no longer able to work on their own, but treatment is available that can help you live longer. What happens when you have kidney disease? The effects of kidney disease on the body may vary depending on the stage of CKD. If you have CKD, your kidneys will progressively lose the ability to perform their functions. The main job of the kidneys is to filter waste and excess fluid from the blood and balance salts and minerals like calcium, potassium, and sodium. Kidneys also produce hormones that your body needs to: manage blood pressure make red blood cells keep bones strong Living with CKD increases the chances of developing: high blood pressure (hypertension) heart disease anemia gout excess potassium in the blood (hyperkalemia) metabolic acidosis immune system challenges bone disease You may not have any symptoms or mild symptoms during the early stages of CKD, but you will start feeling sick as your kidneys fail. How do you know if your kidneys are failing? When your kidneys fail, you may develop generalized symptoms related to kidney functions. These can vary in intensity. Healthcare professionals consider you to be in the stage of kidney failure when your kidney function is reduced to 15% or less. Kidney failure signs and symptoms may include: dark urine edema (swelling) in your ankles, legs, and feet persistent or recurrent headaches itchy skin restless legs unexplained fatigue (low energy) sleep disturbances digestive symptoms like nausea little or no urine muscle cramps generalized aches and pains cognitive challenges like trouble focusing or remembering information Symptoms of end-stage kidney failure may include: pain in your bones vomiting unintended weight loss changes in skin color and texture loss of appetite mental confusion nosebleeds an inability to urinate What are the signs of dying from kidney failure? If you have kidney failure, you're left with about 10–15% of your kidney function. At this point, your kidneys can no longer function on their own. You may experience more severe and persistent symptoms, in addition to: fever seizures coma How long can you live if your kidneys fail? Without any medical treatment, life expectancy after kidney failure is only a few weeks. While there's no way to undo kidney failure, treatment in the form of dialysis or kidney transplant may help you live longer. In fact, once you reach end-stage kidney failure, you need medical treatment to survive. According to the National Kidney Foundation, the average life expectancy for people on dialysis is 5–10 years. Some people receive dialysis for as long as 30 years. Many factors can affect life expectancy if you have kidney failure. Lifestyle changes and medications can help improve your quality of life. For example: getting regular medical check-ups following your doctor's recommendations and treatment plan focusing on a nutrient-dense diet daily physical activity managing related conditions, such as diabetes or high blood pressure Can you survive if both kidneys fail? Most people can survive with one healthy kidney. If both of your kidneys fail, you'll need dialysis or a kidney transplant. Dietary changes and regular exercise may help your treatments work better. Your diet is key to maintaining the proper balance of salts, fluids, and minerals in your body. Exercise strengthens your body and brings oxygen to your tissues. It can also improve your mood and help you sleep at night. What treatments are available for kidney failure? Dialysis Dialysis does the work your kidneys no longer can, filtering your blood to remove waste products. There are two types of dialysis: hemodialysis and peritoneal dialysis. Hemodialysis During hemodialysis, your blood goes through an external filter containing a dialysis solution that removes waste and excess water. Your blood leaves your body and then returns via needles in your arm. You can have hemodialysis at a dialysis center or at home. Peritoneal dialysis With peritoneal dialysis, a surgeon inserts a catheter into your abdomen. Dialysis solution from a bag enters your abdomen through the catheter. Once the bag is empty, you disconnect it and cap the catheter. You can then carry on with everyday activities. The dialysis solution in your abdomen absorbs waste and excess fluid from your body. After several hours, you drain and discard the used dialysis solution through the catheter into an empty bag. You may need to repeat this process 4–6 times a day. You can perform this type of dialysis anywhere. It can also work while you're sleeping with the help of a machine called a cycler. Kidney transplant A kidney transplant is a surgical procedure in which one or both of your kidneys are replaced with a donor kidney. A transplant can be from a living or deceased donor. Your doctor can guide you through the process of finding a living donor or getting on a waitlist. A successful kidney transplant may help you to live longer than if you remained on dialysis. In many cases, donor recipients can live the way they did before they had kidney disease. As with any surgery, risks with transplant surgery are possible. You'll also need to take anti-rejection medication to protect your new kidney from your immune system. This type of medication increases your risk of infection and some types of cancer. The takeaway When your kidneys stop working, you'll need medical treatment to survive. Life expectancy is often reduced to a few weeks if your kidneys fail. However, treatment is available and usually effective to help you feel better and live longer. Signs your kidneys are failing may include swelling, itchiness, aches and pains, weight loss, an inability to urinate, and confusion. Coma is possible in the end stages of kidney failure.
ABC News
11-07-2025
- Health
- ABC News
Indigenous people less likely to be waitlisted for a kidney transplant
There's a gap in the number of Aboriginal and Torres Strait Islander people who are waitlisted for a kidney transplant. A study has found while eight per cent of non-Indigenous dialysis patients were waitlisted, just two per cent of Aboriginal and Torres Strait Islander patients were. In most cases it was because of an incomplete work‐up, because they were awaiting transplant assessment or because their eligibility had not yet been assessed. Guest/s Professor Jacqui Hughes, a kidney specialist at Flinders University and one of the leaders of the National Indigenous Kidney Transplantation Taskforce Professor Jacqui Hughes, a kidney specialist at Flinders University and one of the leaders of the National Indigenous Kidney Transplantation Taskforce Professor Stephen McDonald, a specialist in the epidemiology of kidney disease at The University of Adelaide References
